Vitamin D3 for Life

Live Enlightened

Article

Muscle VDR Deletion, Fibre Structure and Strength in Mice: Full Study

Previous related pageLocal Vitamin D Activation, Airway Defence and Epithelial Integrity: Study SummaryNext related pageMuscle VDR Deletion, Fibre Structure and Strength in Mice: Study Summary
Study at a glance

How was the vitamin D receptor studied in mouse muscles?

Researchers genetically removed the vitamin D receptor from muscle cells in mice. This receptor allows cells to respond to vitamin D signals. They compared muscle size, structure, grip strength and voluntary running with control mice. Removing a receptor is different from having a low vitamin D blood level or taking a supplement.

How did removing the receptor affect mouse muscles?

Mice with the receptor removed had less muscle mass, lower grip strength and shorter running distances. Not every muscle was affected equally. Individual muscle fibres were slightly larger on average, but one muscle section contained fewer fibres and showed an irregular arrangement. This was not simply a case of every fibre becoming smaller. A section count also cannot show when or why the difference arose.

Did gene changes explain why the mice were weaker?

Changes in genes involved in calcium movement and muscle maintenance suggested possible explanations. The study did not directly show that these changes caused the weakness. Small groups of young male mice were used, and the receptor was absent during development. Grip strength and wheel running do not directly test balance, coordination or successful repair after injury.

Did vitamin D doses make a difference to balance in people?

A separate three-year trial compared three vitamin D doses in 373 adults aged 55 to 70. It found no clear difference between dose groups in postural sway, a measure of standing balance. Most participants already had adequate vitamin D, and balance was not the main outcome. Together, these studies support a role for muscle receptors in mice but do not establish that supplements improve human coordination or prevent falls.

Read the full article below ↓

This study tested whether muscle-cell vitamin D receptor function contributes to muscle structure and performance in mice. A complementary human trial discussed below directly measured postural sway, adding a bounded balance comparison. The genetic and supplementation experiments answer different questions. For the companion appraisal, see Muscle VDR Deletion, Fibre Structure and Strength in Mice: Study Summary.

What the experiment tested

Girgis and colleagues crossed mice carrying a conditional Vdr gene with mice expressing Cre under a human skeletal-actin promoter. Their comparison with floxed littermates was intended to distinguish muscle-cell receptor effects from the widespread mineral and developmental consequences of deleting VDR throughout the body. The main functional experiments used young male mice on standard chow. This is a genetic perturbation study, not a dietary vitamin D insufficiency experiment.

The distinction matters when interpreting Vitamin D Receptors. Removing a receptor changes the capacity to respond to its ligand and may affect functions across development. Lower circulating 25-hydroxyvitamin D changes substrate availability while leaving the receptor present. These exposures cannot be treated as equivalent.

How muscle function and structure were measured

The investigators combined body composition, dissected muscle weights, grip testing and voluntary wheel running. Each mouse completed 15 grip attempts in sets of three, with short rests, and force was expressed relative to body weight. Wheel measurements followed 24 hours of acclimatisation and covered the next 24 hours. The body-composition comparison involved five or six mice per group; grip measurements involved six to sixteen, depending on age; and wheel measurements involved seven or eight. These are distinct assays with different sample sizes, rather than one uniform cohort measured in the same way.

Histology assessed fibre size, shape, nuclei and fibre number in muscle sections. Gene-expression measurements examined muscle development, protein turnover and calcium-handling candidates. These molecular measures help generate explanations for a phenotype; they do not establish that every altered transcript caused the functional change.

The main findings

At 13 weeks, lean mass as a proportion of body weight was approximately 70.3% in the muscle-deletion group versus 77.9% in controls, while proportional fat mass was higher. Quadriceps, tibialis anterior, extensor digitorum longus and flexor digitorum longus wet weights were significantly lower. Gastrocnemius weight showed a downward trend rather than a statistically significant difference, and soleus weight was not reduced. Grip strength was lower by roughly 7 to 16% across the reported ages, and wheel-running distance was about 22% lower. The muscle-specific differences matter: a whole-animal performance deficit did not mean that every dissected muscle responded identically.

The structural findings were not simply smaller fibres. Fibres were slightly larger on average, with irregular shapes and more centrally positioned nuclei. A mid-muscle quadriceps section contained fewer fibres, with reported medians of 1,412 versus 2,525. A sectional count is not a direct longitudinal measurement of fibre loss. Developmental differences and changes in muscle geometry remain relevant interpretations.

What the molecular measurements add

The molecular analysis examined three possible contributors to the phenotype: calcium handling, regulation of muscle growth and protein turnover, and cell-cycle-related activity. The calcium results connect with Vitamin D and Calcium, because contraction and relaxation require controlled calcium movement. The growth and turnover measurements ask why overall muscle mass could fall even when average fibre diameter increased. None of these candidate measurements, by itself, establishes the mechanism of weakness.

These measurements place the experiment within Vitamin D and Skeletal Muscle Function. The useful question is whether several observations converge on a coherent explanation and which alternatives remain. The findings do not support a simple account in which receptor deletion uniformly shrinks fibres, increases every breakdown marker and changes all muscles in the same direction.

Strengths and limits of causal interpretation

Restricting the genetic manipulation to muscle strengthens the argument that muscle VDR has a role beyond the systemic effects of mineral imbalance. Combining functional and structural measurements is more informative than measuring receptor expression alone. Nevertheless, the deletion was not an adult-onset human intervention. It cannot distinguish every developmental effect from a maintenance function in mature muscle.

Whole-muscle Vdr expression fell by about half rather than disappearing. Residual signal may come from non-muscle cells or incomplete recombination. Small, male-only experimental groups limit precision and generalisability. Numerous candidate outcomes were tested, so an isolated statistically significant transcript should be interpreted within the overall pattern, not as a separately proven mechanism.

Coordination, repair and human translation

Grip and wheel activity are not direct tests of neuromuscular junction function, balance or coordination. The study therefore supports part of the contraction-and-strength question while leaving the coordination component unresolved. Central nuclei suggest remodelling but do not establish a beneficial repair response or recovery after injury.

An appropriate next step would separate adult receptor function from development, measure force in isolated muscle, examine calcium handling directly and test both sexes. Human trials would then be needed to connect a defined intervention with relevant functional outcomes. Neither this mouse result nor the presence of a receptor specifies a supplement dose.

Separating muscle size, force and everyday movement

A reduction in muscle mass can contribute to lower overall force, but the relationship is not one-to-one. Fibre arrangement, the number of functioning fibres, their contractile properties and neural recruitment all matter. The investigators measured grip in the whole animal rather than the force generated by an isolated fibre. Consequently, their results establish a performance phenotype while leaving the relative contribution of these components unresolved. Calling this a direct demonstration of defective excitation: contraction coupling would go beyond the measurements.

Normalising grip to body weight helps address differences in the size of the animals. It does not turn the measurement into force per unit of contractile muscle. Body weight includes tissues other than muscle, and the deletion altered body composition. A useful complementary experiment would measure muscle-specific force relative to physiological cross-sectional area. That would help distinguish having less functioning muscle from producing less force with a comparable amount of muscle.

The wheel-running findings help distinguish reduced movement from simply spending less time at the wheel. The proportion of time running was not significantly different between groups during either the light or dark period. Running speed was lower, however, and total distance fell. That pattern makes a purely time-on-task explanation less persuasive, although voluntary running still combines motivation, fatigue and movement capacity. It is not an isolated-muscle endurance test. Grip and wheel measurements also recruit different muscles and involve brief versus sustained activity, so their convergence supports a functional phenotype without identifying a single physiological defect.

Why larger fibres can coexist with less muscle

The apparently larger fibres are a particularly useful corrective to a simple atrophy narrative. Overall muscle size depends on more than the average area of the fibres that remain in one section. If the section contains fewer fibres, its individual fibres can be larger while the muscle as a whole weighs less. Irregular outlines and changes in the distribution of fibre sizes add further complexity. An average should not obscure the structural organisation visible in the tissue.

The reported section counts do not establish when or why the difference in fibre number arose. Histology did not show a clear increase in collagen staining, so widespread fibrosis was not supported as the explanation. Cleaved-caspase-3 staining identified a cluster of apparently apoptotic fibres in one knockout mouse, but the finding was absent from the other knockout and control specimens examined. It therefore cannot be generalised into ongoing widespread fibre death at 13 weeks. Central nuclei and irregular outlines indicate altered organisation; showing successful repair would require a defined injury, a recovery time course and restored function. Vitamin D and Tissue Repair provides that broader context without turning these baseline images into a recovery experiment.

What altered gene expression can and cannot explain

The calcium-handling findings differed between muscles. In quadriceps, Serca2b, Serca3 and calbindin transcripts were lower, while Serca2a did not differ significantly. In soleus, all three tested SERCA transcripts were lower; the calbindin comparison was not significant. SERCA pumps return calcium to intracellular stores, helping muscle relax and prepare for another contraction. These results therefore identify a plausible contraction: relaxation mechanism. However, messenger RNA, pump abundance, pump activity and calcium transients are separate measurements. The experiment did not establish each step or show that restoring one pump rescued force.

The cell-cycle findings were selective rather than a reduction in every measured regulator. Cyclins D1, D2 and D3 and the cyclin-dependent kinases Cdk2 and Cdk4 were lower in quadriceps and soleus, while the tested inhibitors p19, p21 and p27 were unchanged in quadriceps. Because these measurements came from whole muscle, they cannot locate the response exclusively in mature fibres or establish a rate of satellite-cell proliferation. They are compatible with altered developmental or maintenance programmes, but an adult-onset deletion and cell-resolved measurements would be needed to distinguish those possibilities.

The fibre-type and mitochondrial measurements narrow the interpretation in another direction. Type 2B fibres predominated in both groups, with no clear redistribution among the reported types. Succinate-dehydrogenase staining and the measured oxidative-phosphorylation protein bands also showed no clear group difference. These are relevant to Vitamin D and Mitochondrial Function, but they are not direct measurements of oxygen consumption, ATP production or fatigue resistance. The data argue against an obvious fibre-type switch or a large change in the assayed protein abundance; they leave more subtle metabolic explanations open.

Receptor deletion and vitamin D availability answer different questions

The experiment is most informative about a receptor-dependent contribution within the targeted tissue. A dietary or clinical study of low vitamin D asks whether changing ligand availability alters function while the receptor remains present. Vitamin D Status vs Vitamin D Effect explains why a blood measurement cannot stand in for either receptor function or measured strength. Vitamin D Activation adds a further distinction: precursor availability and conversion to the active metabolite are regulated steps that this knockout experiment did not manipulate.

Vitamin D and Gene Expression explains why the receptor can affect a collection of cellular processes rather than one isolated contractile protein. The tissue phenotype in turn sits within Vitamin D and Muscle Function. Linking these levels does not establish that the observed mouse phenotype is the mechanism of weakness in every person with a low blood measurement.

The protein-turnover results are especially important for Vitamin D and Protein Metabolism. Murf1 expression was lower in quadriceps and soleus, while Mafbx was significantly lower in soleus and tibialis anterior and showed only a downward trend in quadriceps. These ubiquitin-ligase findings oppose a simple explanation based on uniformly increased expression of protein-breakdown machinery. Myostatin was significantly lower in soleus, the muscle whose weight was preserved. The study did not measure protein synthesis and degradation rates directly, so these associations identify candidate compensations rather than a complete account of protein balance.

How much confidence the measurements support

The figures make clear why the unit of analysis matters. Fibre diameter was assessed in at least 900 fibres per genotype, but fibres sampled from the same animal share its genotype, development and environment. That large count cannot be interpreted as 900 independent biological replications. Most comparisons used small animal groups, and the reported statistical approach generally used unpaired tests with a 0.05 significance threshold. Numerous candidate genes and tissue comparisons were examined, without a stated general multiple-testing correction. Borderline transcript results therefore carry less weight than the convergent mass, morphology and performance findings.

The receptor perturbation supplies causal leverage, but its causal question is specific. The study compared a developmental genetic model with littermate controls; it did not randomise mature animals to receptor restoration, measure a dose response to vitamin D, or follow ageing into late life. A useful follow-up would test whether restoring receptor function or a proposed downstream pathway reverses a defined defect. Such a rescue would distinguish an associated molecular change from a mediator that actually contributes to impaired performance.

Human balance requires a direct test

A complementary human trial examined postural sway rather than inferring coordination from strength. Burt and colleagues randomised 373 adults aged 55 to 70 to 400, 4,000 or 10,000 IU/day vitamin D3 for three years. Participants stood on firm or foam surfaces with eyes open or closed. The study found no significant between-group sway difference. Improvement on foam surfaces occurred across groups and could reflect learning rather than a dose effect.

Balance was a secondary outcome in a trial powered for bone measurements. Participants generally had adequate vitamin D status, and degradation of some high-dose preparations complicated exposure during the later trial. Moreover, although the discussion describes participants as without a fall history, Table 1 records previous-year falls in each group. The cohort should not be described as uniformly free of previous falls. These findings address sensory-motor balance under a defined test; they neither establish improved neuromuscular coordination from supplementation nor explain the mouse grip-strength phenotype.

Conclusion

The most defensible conclusion is that muscle-cell VDR contributes to muscle structure and performance in this mouse model. The combination of reduced muscle mass, altered fibre organisation and lower grip strength provides stronger mechanistic evidence than receptor detection alone. It remains distinct from evidence that correcting low vitamin D improves coordination or prevents falls in people.

Sources and publication details

Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. Girgis CM and colleagues. Journal of Cachexia, Sarcopenia and Muscle. 2019;10(6):1228 to 1240. DOI: 10.1002/jcsm.12460. PMID: 31225722.

Postural Balance Effects Associated with 400, 4000 or 10,000 IU Vitamin D3 Daily for Three Years: A Secondary Analysis of a Randomized Clinical Trial. Burt Lauren A. and colleagues. Nutrients. 2020;12(2):527. DOI: 10.3390/nu12020527. PMID: 32092887.

Related reading

Original sources